ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

NCCS Appointment Marks Transition To New Structure.

March 17, 2000

Bypass Budget Will Call For 15-percent Increase

February 18, 2011

Randomized Trial Finds Supplement Use Didn’t Prevent Prostate Cancer After 5 Years.

October 31, 2008

International Group Plans Survey On Thrombosis Risk

July 27, 2001

In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000

November 10, 1989

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977